BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Azoulay E, Bauer PR, Mariotte E, Russell L, Knoebl P, Martin-Loeches I, Pène F, Puxty K, Povoa P, Barratt-Due A, Garnacho-Montero J, Wendon J, Munshi L, Benoit D, von Bergwelt-Baildon M, Maggiorini M, Coppo P, Cataland S, Veyradier A, Van de Louw A; Nine-i Investigators. Expert statement on the ICU management of patients with thrombotic thrombocytopenic purpura. Intensive Care Med 2019;45:1518-39. [PMID: 31588978 DOI: 10.1007/s00134-019-05736-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Li XM, Mo XY, Huang GQ, Zhang FJ. Therapeutical plasma exchange for thrombotic thrombocytopenic purpura in the emergency department: A single center experience. Am J Emerg Med 2021;46:556-9. [PMID: 33214018 DOI: 10.1016/j.ajem.2020.11.019] [Reference Citation Analysis]
2 Kalpatthi R, Kiss JE. Thrombotic Thrombocytopenic Purpura, Heparin-Induced Thrombocytopenia, and Disseminated Intravascular Coagulation. Crit Care Clin 2020;36:357-77. [PMID: 32172818 DOI: 10.1016/j.ccc.2019.12.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Van de Louw A, Mariotte E, Darmon M, Cohrs A, Leslie D, Azoulay E. Outcomes in 1096 patients with severe thrombotic thrombocytopenic purpura before the Caplacizumab era. PLoS One 2021;16:e0256024. [PMID: 34383822 DOI: 10.1371/journal.pone.0256024] [Reference Citation Analysis]
4 White A, Martin R, Sew K, Stucke A, Cook R. Economic impact of a rapid, on‐demand ADAMTS‐13 activity assay for the diagnosis of thrombotic thrombocytopenic purpura. Res Pract Thromb Haemost 2022;6. [DOI: 10.1002/rth2.12711] [Reference Citation Analysis]
5 Renaud A, Caristan A, Seguin A, Agard C, Blonz G, Canet E, Eveillard M, Godmer P, Graveleau J, Lecouffe-Desprets M, Maisonneuve H, Perrin F, Hamidou M, Néel A. Deleterious neurological impact of diagnostic delay in immune-mediated thrombotic thrombocytopenic purpura. PLoS One 2021;16:e0260196. [PMID: 34797873 DOI: 10.1371/journal.pone.0260196] [Reference Citation Analysis]
6 Azrieh B, Alsaud A, Obeidat K, Ashour A, Elebbi S, Mohamed SF, Abdelaty MA, Akkari A, Elbuzidi AA, Yassin MA. Rituximab Twice Weekly for Refractory Thrombotic Thrombocytopenic Purpura in a Critically Ill Patient with Acute Respiratory Distress Syndrome. Case Rep Oncol 2020;13:153-7. [PMID: 32231537 DOI: 10.1159/000505236] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Galstyan GM, Maschan AA, Klebanova EE, Kalinina II. Treatment of thrombotic thrombocytopenic purpura. Terapevticheskii arkhiv 2021;93:736-45. [DOI: 10.26442/00403660.2021.06.200894] [Reference Citation Analysis]
8 Ferro JM, Infante J. Cerebrovascular manifestations in hematological diseases: an update.J Neurol. 2021;268:3480-3492. [PMID: 33586004 DOI: 10.1007/s00415-021-10441-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Fodil S, Zafrani L. Severe Thrombotic Thrombocytopenic Purpura (TTP) with Organ Failure in Critically Ill Patients. JCM 2022;11:1103. [DOI: 10.3390/jcm11041103] [Reference Citation Analysis]
10 Cilla N, Dallemagne J, Vanhove M, Stordeur P, Motte S, De Wilde V. Delayed Thrombotic Complications in a Thrombotic Thrombocytopenic Purpura Patient Treated With Caplacizumab. J Hematol 2020;9:84-8. [PMID: 32855757 DOI: 10.14740/jh614] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
11 Orieux A, Boyer A, Dewitte A, Combe C, Rubin S. [Acute kidney injury in intensive care unit: A review]. Nephrol Ther 2021:S1769-7255(21)00508-3. [PMID: 34872863 DOI: 10.1016/j.nephro.2021.07.324] [Reference Citation Analysis]
12 Galstyan GM, Klebanova EE. [Diagnosis of thrombotic thrombocytopenic purpura]. Ter Arkh 2020;92:207-17. [PMID: 33720596 DOI: 10.26442/00403660.2020.12.200508] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Culler CA, Vigani A, Ripoll AZ, Gareau A, Suter SE. Centrifugal therapeutic plasma exchange in dogs with immune-mediated hemolytic anemia (2016-2018): 7 cases. J Vet Emerg Crit Care (San Antonio) 2022. [PMID: 35499963 DOI: 10.1111/vec.13196] [Reference Citation Analysis]
14 Song JC, Liu SY, Zhu F, Wen AQ, Ma LH, Li WQ, Wu J; Critical Care Medicine Committee of Chinese People’s Liberation Army (PLA); Chinese Society of Laboratory Medicine, Chinese Medical Association. Expert consensus on the diagnosis and treatment of thrombocytopenia in adult critical care patients in China. Mil Med Res 2020;7:15. [PMID: 32241296 DOI: 10.1186/s40779-020-00244-w] [Reference Citation Analysis]
15 Raval JS, Rollins-Raval MA, Mazepa MA, Park YA. Heterogeneity of diagnosis, treatment, and management for immune thrombotic thrombocytopenic purpura: Are we still peering through the looking glass? J Clin Apher 2020;35:236-7. [PMID: 32449953 DOI: 10.1002/jca.21777] [Reference Citation Analysis]
16 Mori F, Nardini I, Caricasole A, Amega NS, Farina C. Characterization of a plasma-derived double-viral-inactivated factor VIII concentrate (antihaemophilic factor [human]): Focus on TTP treatment. Haemophilia 2021;27:e409-11. [PMID: 33529361 DOI: 10.1111/hae.14260] [Reference Citation Analysis]
17 Chen JK, Tang N, Wang X, Huang M, Zhang C. A Case of Parturient with Hereditary Thrombotic Thrombocytopenic Purpura: Case Report of a Novel Variant. Semin Thromb Hemost 2021. [PMID: 34388840 DOI: 10.1055/s-0041-1732466] [Reference Citation Analysis]
18 Li H, Gao C, Lin L, Zhang G, Fan S, Hai X. Pharmacokinetics of cefoperazone/sulbactam in critically Ill thrombotic thrombocytopenic purpura patients undergoing therapeutic plasma exchange. Clinical Pharmacy Therapeu. [DOI: 10.1111/jcpt.13660] [Reference Citation Analysis]
19 Lemiale V, Valade S, Mariotte E. Unresponsive Thrombotic Thrombocytopenic Purpura (TTP): Challenges and Solutions. Ther Clin Risk Manag 2021;17:577-87. [PMID: 34113115 DOI: 10.2147/TCRM.S205632] [Reference Citation Analysis]
20 Di Micco P, Camporese G, Cardillo G, Lodigiani C, Carannante N, Annunziata A, Fiorentino G, Russo V, Imbalzano E. Pathophysiology of Vaccine-Induced Prothrombotic Immune Thrombocytopenia (VIPIT) and Vaccine-Induced Thrombocytopenic Thrombosis (VITT) and Their Diagnostic Approach in Emergency. Medicina (Kaunas) 2021;57:997. [PMID: 34684034 DOI: 10.3390/medicina57100997] [Reference Citation Analysis]